Skip to content

CVE-2026-24217

Nvidia Bionemo Framework path traversal

8.8 HIGHEPSS 0.76%
  1. Published20 May 2026

Description

NVIDIA BioNeMo Core for Linux contains a vulnerability where a user could cause a path traversal by loading a malicious file. A successful exploit of this vulnerability might lead to code execution, denial of service, information disclosure, and data tampering.

CVSS 3.1 breakdown

Attack vectorNetwork
Attack complexityLow
Privileges requiredNone
User interactionRequired
ScopeUnchanged
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Affected products

Nvidia Bionemo Framework< 2026-04-03

Remediation

Fixed in
Nvidia Bionemo Framework≥ 2026-04-03

Frequently asked

Is CVE-2026-24217 being actively exploited?

CVE-2026-24217 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.76%.

How severe is CVE-2026-24217?

CVE-2026-24217 has a CVSS 3.1 base score of 8.8, rated high. EPSS estimates a 0.76% probability of exploitation.

Which products are affected by CVE-2026-24217?

Affected products include Nvidia Bionemo Framework.

How do I fix CVE-2026-24217?

Upgrade affected software to a fixed version, for example Nvidia Bionemo Framework 2026-04-03 or later, then confirm no affected versions remain in your inventory.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2026-24217 against the real software inventory on every managed device, as each hourly inventory arrives. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

Get Patch this first every Monday

Five vulnerabilities that matter this week, ranked on real exploitation. Plain language, one email, no spam.

You can unsubscribe with one click from every issue. We handle your details as described in our privacy policy.

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.